- Home
- YGMZ vs CLYM Comparison
YGMZ vs CLYM Comparison
Compare YGMZ & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YGMZ
- CLYM
- Stock Information
- Founded
- YGMZ 2002
- CLYM 2018
- Country
- YGMZ China
- CLYM United States
- Employees
- YGMZ 195
- CLYM N/A
- Industry
- YGMZ Transportation Services
- CLYM
- Sector
- YGMZ Consumer Discretionary
- CLYM
- Exchange
- YGMZ Nasdaq
- CLYM NYSE
- Market Cap
- YGMZ 101.2M
- CLYM 83.1M
- IPO Year
- YGMZ 2020
- CLYM 2021
- Fundamental
- Price
- YGMZ $1.35
- CLYM $1.19
- Analyst Decision
- YGMZ
- CLYM
- Analyst Count
- YGMZ 0
- CLYM 0
- Target Price
- YGMZ N/A
- CLYM N/A
- AVG Volume (30 Days)
- YGMZ 242.6K
- CLYM 125.8K
- Earning Date
- YGMZ 01-01-0001
- CLYM 05-19-2025
- Dividend Yield
- YGMZ N/A
- CLYM N/A
- EPS Growth
- YGMZ N/A
- CLYM N/A
- EPS
- YGMZ N/A
- CLYM N/A
- Revenue
- YGMZ $55,805,416.00
- CLYM N/A
- Revenue This Year
- YGMZ N/A
- CLYM N/A
- Revenue Next Year
- YGMZ N/A
- CLYM N/A
- P/E Ratio
- YGMZ N/A
- CLYM N/A
- Revenue Growth
- YGMZ N/A
- CLYM N/A
- 52 Week Low
- YGMZ $0.64
- CLYM $1.05
- 52 Week High
- YGMZ $4.35
- CLYM $10.23
- Technical
- Relative Strength Index (RSI)
- YGMZ 67.80
- CLYM N/A
- Support Level
- YGMZ $1.20
- CLYM N/A
- Resistance Level
- YGMZ $1.38
- CLYM N/A
- Average True Range (ATR)
- YGMZ 0.13
- CLYM 0.00
- MACD
- YGMZ 0.01
- CLYM 0.00
- Stochastic Oscillator
- YGMZ 93.62
- CLYM 0.00
About YGMZ MingZhu Logistics Holdings Limited
MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. Its segments are the trucking business, car owner services business, and liquor distribution business. It generates the majority of its revenue from the trucking segment.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.